February 2007 Summarizes a study that analyzes factors associated with the risk of drug addiction among 19- to 21-year-old Hispanic women born in the United States as compared with immigrants.
December 2008 Highlights results from a pilot study suggesting that lofexidine, an anti-hypertensive medication, can enhance success rates among patients taking maintenance naltrexone to avoid opioid relapse.
November 2009 Highlights the need for research to assess and find solutions to a potential rise in substance abuse among service men and women, veterans, and their families.
December 2010 Announces three new NIDA National Advisory Council on Drug Abuse members and describes their drug abuse and addiction research experience.
July 2011 Summarizes a study to determine whether a stress-related biological marker in saliva can predict how long a drug user will remain in treatment.
February 2013
Several factors contribute to treatment professionals’ stress and burnout, including how much influence they feel they have in their organization and their caseload. Surprisingly, a NIDA-supported study found that the link between staff stress and burnout was weaker in programs with higher patient caseloads than those with lower caseloads. In addition, program administrators can help counselors reduce their stress by giving them a voice in organizational policies and procedures.
January 2014 Ketoprofen, an anti-inflammatory agent commonly prescribed to treat arthritis, reduces neuronal damage in rats that have been exposed to chronic stress and methamphetamine. If this finding of a recent NIDA-supported study extrapolates to humans, anti-inflammatory medications may gain a place in the treatment of methamphetamine addiction.
February 2018 Stressful life events are associated with reductions in a person’s chances of becoming or remaining abstinent from drugs for at least 3 years.
